title: Cost-effectiveness of treatments for diabetic macular oedema: should we pay more attention to the appraisal and reporting of economic evaluations?
authors.affiliation: Department of Ophthalmology, Careggi Hospital Eye Clinic, University of Florence, , Florence, Italy.
authors.forename: Gianni
authors.initials: G
authors.lastname: Virgili
authors.forename: Mariacristina
authors.initials: M
authors.lastname: Parravano
authors.forename: Francesca
authors.initials: F
authors.lastname: Menchini
authors.forename: Massimo
authors.initials: M
authors.lastname: Brunetti
mesh_terms: D020533:Angiogenesis Inhibitors / Q000191:economics*; D003362:Cost-Benefit Analysis; D003930:Diabetic Retinopathy / Q000188:drug therapy / Q000191:economics*; D006304:Health Status; D006801:Humans; D008269:Macular Edema / Q000188:drug therapy / Q000191:economics*; D017063:Outcome Assessment, Health Care; D026712:Value of Life
chemical_list: D020533:Angiogenesis Inhibitors
keywords: Retina